| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Roger Klein Moreira | |
| P433 | issue | 11 | |
| P304 | page(s) | 1728-1734 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Archives of Pathology & Laboratory Medicine | Q4787305 |
| P1476 | title | Hepatic stellate cells and liver fibrosis | |
| P478 | volume | 131 |
| Q92157142 | (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway |
| Q33850019 | 20S-Protopanaxadiol, an aglycosylated ginsenoside metabolite, induces hepatic stellate cell apoptosis through liver kinase B1-AMP-activated protein kinase activation |
| Q34516513 | A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells |
| Q47115217 | AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M. |
| Q36069681 | Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs |
| Q35788567 | All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells |
| Q41022348 | Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis |
| Q38758909 | Anticytoproliferative effect of Vitamin C on rat hepatic stellate cell |
| Q47235548 | Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis |
| Q42991560 | Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway |
| Q34446710 | Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition |
| Q38250325 | Autophagic effects of Chaihu (dried roots of Bupleurum Chinense DC or Bupleurum scorzoneraefolium WILD). |
| Q35611763 | Biological properties of extracellular vesicles and their physiological functions. |
| Q39754535 | Changes in E-NTPDase 3 expression and extracellular nucleotide hydrolysis during the myofibroblast/lipocyte differentiation |
| Q60931087 | Chemoresistance and the Self-Maintaining Tumor Microenvironment |
| Q34499095 | Chunggan extract, a traditional herbal formula, ameliorated alcohol-induced hepatic injury in rat model |
| Q43132880 | Components of the mitogen-activated protein kinase cascade are activated in hepatic cells by Echinococcus multilocularis metacestode |
| Q26781477 | Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma |
| Q37209512 | Cytokine mediated tissue fibrosis |
| Q55199271 | DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis. |
| Q36665479 | Defects in MAP1S-mediated autophagy cause reduction in mouse lifespans especially when fibronectin is overexpressed |
| Q38967823 | Detecting transforming growth factor-β release from liver cells using an aptasensor integrated with microfluidics |
| Q84382772 | Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis |
| Q36328115 | Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway |
| Q47119118 | Drugs and Targets in Fibrosis |
| Q37289563 | Effect of Fuzheng Huayu formula and its actions against liver fibrosis |
| Q41964650 | Effect of caloric restriction on hepatic sinusoidal system and stellate cells in mice |
| Q34311806 | Effect of dietary supplementation of grape skin and seeds on liver fibrosis induced by dimethylnitrosamine in rats |
| Q35840228 | Effect of nanostructured thin film on minimally invasive surgery devices applications: characterization, cell cytotoxicity evaluation and an animal study in rat. |
| Q30462755 | Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. |
| Q37269913 | Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis |
| Q57108017 | Elimination of Wnt secretion from stellate cells is dispensable for zonation and development of liver fibrosis following hepatobiliary injury |
| Q93067039 | Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis |
| Q37198484 | Ethyl Acetate Fraction of Amomum xanthioides Exerts Antihepatofibrotic Actions via the Regulation of Fibrogenic Cytokines in a Dimethylnitrosamine-Induced Rat Model. |
| Q36100069 | Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines |
| Q36407214 | Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. |
| Q43103828 | Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. |
| Q53075817 | Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study. |
| Q36672445 | Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure |
| Q34091329 | Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β. |
| Q33608724 | F‑actin cytoskeleton reorganization is associated with hepatic stellate cell activation |
| Q38973639 | GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis |
| Q58574738 | Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis |
| Q35224659 | Gallic acid induces necroptosis via TNF-α signaling pathway in activated hepatic stellate cells. |
| Q55966751 | Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation |
| Q64936019 | Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro. |
| Q92059925 | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease |
| Q40453944 | Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. |
| Q93140401 | Hepatic fibrosis: Avenues of investigation and clinical implications |
| Q50578568 | Hepatic stellate cell-specific gene silencing induced by an artificial microRNA for antifibrosis in vitro. |
| Q45377597 | Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF). |
| Q40860773 | Hepatic stellate cells increase in Toxoplasma gondii infection in mice. |
| Q34690834 | Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells |
| Q40000876 | Herbal compound 861 regulates mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells |
| Q94454420 | Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases |
| Q37371562 | Histone demethylase retinoblastoma binding protein 2 regulates the expression of α-smooth muscle actin and vimentin in cirrhotic livers |
| Q93108306 | Human Amnion Epithelial Cell Therapy for Chronic Liver Disease |
| Q64085516 | Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis |
| Q38389648 | Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression |
| Q42376297 | IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs |
| Q57494350 | Immunodeficiency caused by cirrhosis |
| Q41907239 | Immunohistochemical localization of transforming growth factor β-1 and its relationship with collagen expression in advanced liver fibrosis due to biliary atresia |
| Q26751474 | Immunological aspects of liver cell transplantation |
| Q41922753 | In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice |
| Q41835740 | Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice |
| Q92861341 | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C |
| Q38549556 | Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells |
| Q37417134 | Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma |
| Q93090410 | Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis |
| Q55259288 | Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish. |
| Q34677793 | Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems |
| Q34728267 | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies |
| Q26765808 | Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases |
| Q36929278 | Lactoferrin Enhanced Apoptosis and Protected Against Thioacetamide-Induced Liver Fibrosis in Rats |
| Q37047177 | Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. |
| Q41895573 | Liver extracellular vesicles in health and disease |
| Q35918640 | Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways |
| Q50441063 | MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide |
| Q38491316 | Mass spectrometry-based quantitative proteomic profiling of human pancreatic and hepatic stellate cell lines |
| Q57799472 | Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation |
| Q64057399 | Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis |
| Q26745839 | Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation |
| Q47167414 | MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. |
| Q37613598 | MicroRNAs in Liver Disease: Bench to Bedside |
| Q26740198 | MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling |
| Q34326022 | Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics |
| Q39063947 | Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective |
| Q37739608 | NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease. |
| Q38773619 | New role and molecular mechanism of Gadd45a in hepatic fibrosis |
| Q54976874 | Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function. |
| Q36165804 | Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis |
| Q30464087 | Noninvasive tools to assess hepatic fibrosis: ready for prime time? |
| Q37421485 | Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patients |
| Q39337824 | Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation |
| Q35606813 | Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice |
| Q36175084 | Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells |
| Q28071596 | Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells |
| Q37697606 | Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ. |
| Q58577233 | Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing |
| Q91832850 | Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases |
| Q37388018 | Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease |
| Q41517897 | Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. |
| Q41349258 | Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism |
| Q51459972 | Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells. |
| Q58758006 | Role of canonical Hedgehog signaling pathway in liver |
| Q64941384 | Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. |
| Q43093402 | Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum |
| Q36456025 | Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling |
| Q38961328 | Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings |
| Q39699092 | Serial change of liver stiffness measured by acoustic radiation force impulse imaging in chronic liver disease: correlation with biochemical markers |
| Q38996795 | Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease. |
| Q89272035 | Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice |
| Q43187791 | Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats |
| Q57035112 | Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis |
| Q99710987 | T. gondii infection induces IL-1R dependent chronic cachexia and perivascular fibrosis in the liver and skeletal muscle |
| Q34045941 | TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion |
| Q90695373 | Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor |
| Q35067772 | The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling |
| Q35097640 | The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells |
| Q36545542 | The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells |
| Q42099861 | The impact of high fat diets on physiological changes in euthyroid and thyroid altered rats |
| Q34623670 | The role of hepatic myofibroblasts in liver cirrhosis in fallow deer (Dama dama) naturally infected with giant liver fluke (Fascioloides magna) |
| Q35246561 | Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver. |
| Q42370433 | Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice. |
| Q33801435 | Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices |
| Q35740215 | microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. |
| Q39009283 | β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation |
Search more.